Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Carolin Thomas1, Lia Wurzer2, Ernst Malle2
1Laboratory of Energy Metabolism Institute of Translational Medicine Department of Health Sciences and Technology ETH Zurich, Schwerzenbach, Switzerland.
Abstract:
Age-associated diseases represent a growing burden for global health systems in our aging society. Consequently, we urgently need innovative strategies to counteract these pathological disturbances. Overwhelming generation of reactive oxygen species (ROS) is associated with age-related damage, leading to cellular dysfunction and, ultimately, diseases. However, low-dose ROS act as crucial signaling molecules and inducers of a vaccination-like response to boost antioxidant defense mechanisms, known as mitohormesis. Consequently, modulation of ROS homeostasis by nutrition, exercise, or pharmacological interventions is critical in aging. Numerous nutrients and approved drugs exhibit pleiotropic effects on ROS homeostasis. In the current review, we provide an overview of drugs affecting ROS generation and ROS detoxification and evaluate the potential of these effects to counteract the development and progression of age-related diseases. In case of inflammation-related dysfunctions, cardiovascular- and neurodegenerative diseases, it might be essential to strengthen antioxidant defense mechanisms in advance by low ROS level rises to boost the individual ROS defense mechanisms. In contrast, induction of overwhelming ROS production might be helpful to fight pathogens and kill cancer cells. While we outline the potential of ROS manipulation to counteract age-related dysfunction and diseases, we also raise the question about the proper intervention time and dosage.
Insights
Reactive oxygen species (ROS) play a dual role in aging. Low doses boost antioxidant defenses via mitohormesis, while high doses can cause damage, highlighting the need for careful ROS modulation in age-related diseases.
Area of Science:
- Biogerontology
- Cellular Biology
- Pharmacology
Background:
- Aging populations face increasing age-associated diseases.
- Reactive oxygen species (ROS) contribute to age-related cellular dysfunction and disease.
- Mitohormesis, a process induced by low-dose ROS, enhances antioxidant defenses.
Purpose of the Study:
- To review drugs that modulate ROS generation and detoxification.
- To evaluate the potential of ROS manipulation in counteracting age-related diseases.
- To discuss the critical role of ROS homeostasis in aging.
Main Methods:
- Literature review of drugs affecting ROS.
- Analysis of ROS effects on age-related disease progression.
- Evaluation of ROS modulation strategies for healthspan.
Main Results:
- Numerous nutrients and drugs impact ROS homeostasis.
- Low ROS levels can bolster antioxidant defenses, while high levels may be cytotoxic.
- ROS manipulation presents potential for treating age-related conditions.
Conclusions:
- Targeting ROS homeostasis is crucial for combating age-related diseases.
- Strategic use of ROS modulation, considering dose and timing, is key.
- Further research is needed on optimal ROS intervention strategies for aging.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Oxygen Requirements and Growth Patterns
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Redox Reactions
Electron Transport Chain: Complex III and IV
Peroxisomes


